These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38320494)

  • 1. The Registry-Based Randomized Trial - A Pragmatic Study Design.
    Troxel AB; Hade EM
    NEJM Evid; 2024 Feb; 3(2):EVIDe2300310. PubMed ID: 38320494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of the epidemiology methods and applications: strengths and limitations of observational study designs.
    Colditz GA
    Crit Rev Food Sci Nutr; 2010; 50 Suppl 1(s1):10-2. PubMed ID: 21132580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registry-based randomized clinical trials in surgery: Working with ACS-NSQIP and the AHPBA to conduct pragmatic trials.
    Ecker BL; Brajcich BC; Ellis RJ; Ko CY; D'Angelica MI
    J Surg Oncol; 2022 Jan; 125(1):89-92. PubMed ID: 34897710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Registry-based randomized clinical trials--a new clinical trial paradigm.
    James S; Rao SV; Granger CB
    Nat Rev Cardiol; 2015 May; 12(5):312-6. PubMed ID: 25781411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials.
    Mathes T; Buehn S; Prengel P; Pieper D
    J Clin Epidemiol; 2018 Jan; 93():120-127. PubMed ID: 28951111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commentary: On the levels of patient selection in registry-based randomized controlled trials.
    Lasch F; Weber K; Koch A
    Trials; 2019 Feb; 20(1):100. PubMed ID: 30717778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving pragmatic clinical trial design using real-world data.
    Shortreed SM; Rutter CM; Cook AJ; Simon GE
    Clin Trials; 2019 Jun; 16(3):273-282. PubMed ID: 30866672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding explanatory and pragmatic trials: Examples from randomized controlled trials on vertebroplasty.
    Eneling J; Darsaut TE; Patel M; Raymond J
    Neurochirurgie; 2023 Jan; 69(1):101403. PubMed ID: 36566693
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An approach to the design and implementation of clinical trials of empirical antibiotic therapy in febrile and neutropenic cancer patients.
    Viscoli C; Bruzzi P; Glauser M
    Eur J Cancer; 1995 Nov; 31A(12):2013-22. PubMed ID: 8562158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Registry-based randomized controlled trials- what are the advantages, challenges, and areas for future research?
    Li G; Sajobi TT; Menon BK; Korngut L; Lowerison M; James M; Wilton SB; Williamson T; Gill S; Drogos LL; Smith EE; Vohra S; Hill MD; Thabane L;
    J Clin Epidemiol; 2016 Dec; 80():16-24. PubMed ID: 27555082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From randomized trials to registry studies: translating data into clinical information.
    Brown ML; Gersh BJ; Holmes DR; Bailey KR; Sundt TM
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):613-20. PubMed ID: 18679381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ethical responsibilities toward indirect and collateral participants in pragmatic clinical trials.
    Smalley JB; Merritt MW; Al-Khatib SM; McCall D; Staman KL; Stepnowsky C
    Clin Trials; 2015 Oct; 12(5):476-84. PubMed ID: 26374687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Realization of design regarding experimental research in the clinical real-world research].
    He Q; Shi JP
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):519-523. PubMed ID: 29699050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study control, violators, inclusion criteria and defining explanatory and pragmatic trials.
    McMahon AD
    Stat Med; 2002 May; 21(10):1365-76. PubMed ID: 12185890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale and design of the TAILOR-PCI digital study: Transitioning a randomized controlled trial to a digital registry.
    Pereira NL; Avram R; So DY; Iturriaga E; Byrne J; Lennon RJ; Murthy V; Geller N; Goodman SG; Rihal C; Rosenberg Y; Bailey K; Pletcher MJ; Marcus GM; Farkouh ME; Olgin JE
    Am Heart J; 2021 Feb; 232():84-93. PubMed ID: 33129990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pragmatic controlled clinical trials in primary care: the struggle between external and internal validity.
    Godwin M; Ruhland L; Casson I; MacDonald S; Delva D; Birtwhistle R; Lam M; Seguin R
    BMC Med Res Methodol; 2003 Dec; 3():28. PubMed ID: 14690550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized controlled trials and neurosurgery: the ideal fit or should alternative methodologies be considered?
    Mansouri A; Cooper B; Shin SM; Kondziolka D
    J Neurosurg; 2016 Feb; 124(2):558-68. PubMed ID: 26315006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pragmatic clinical trials.
    Macpherson H
    Complement Ther Med; 2004; 12(2-3):136-40. PubMed ID: 15561524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new 'mechanistic-practical" framework for designing and interpreting randomized trials.
    Karanicolas PJ; Montori VM; Devereaux PJ; Schünemann H; Guyatt GH
    J Clin Epidemiol; 2009 May; 62(5):479-84. PubMed ID: 18468856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.